News
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to ...
52m
InvestorsHub on MSNHims and Hers shares drop after revenue falls short amid GLP-1 scrutiny
Shares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of ...
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
Consensus analyst estimates for Novo Nordisk (NVO) earnings per share and revenue land at $0.92 and $11.9 billion, ...
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
Pediatricians in Utah can prescribe weight loss drugs for adolescents over 12 years of age, according to the American Academy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results